Presentation TCT 2025 Clinical Evidence Experience with First Human Use Presenter: Alexandre Abizaid October 28, 2025 REGISTER for free or LOG IN to view this content TCT 2025 Up Next Presentation TCT 2025 Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers? Presenter: Gregg W. Stone October 28, 2025 More slides + Presentation TCT 2025 Digital Versus Invasive Assessment of Functional Lesion Significance: Are Clinical Outcomes Studies Needed If the In Vivo Correlations are Great? Presenter: Bon-Kwon Koo October 28, 2025 Presentation TCT 2025 Moving to Randomized SCAI A Shock CAD Phenotype Approval Studies: Barriers & Solutions Presenter: Mitchell W. Krucoff October 28, 2025 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation TCT 2025 Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers? Presenter: Gregg W. Stone October 28, 2025
Presentation TCT 2025 Digital Versus Invasive Assessment of Functional Lesion Significance: Are Clinical Outcomes Studies Needed If the In Vivo Correlations are Great? Presenter: Bon-Kwon Koo October 28, 2025
Presentation TCT 2025 Moving to Randomized SCAI A Shock CAD Phenotype Approval Studies: Barriers & Solutions Presenter: Mitchell W. Krucoff October 28, 2025